← Leaderboards
Christiane Ferran
Beth Israel Deaconess Medical Center
$11,467,818
Attributed
$18,589,625
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,589,625 · 12
By mechanism
R01$13,651,783 · 6
T32$3,124,372 · 1
R21$1,299,750 · 3
R56$327,250 · 1
T35$186,470 · 1
Top collaborators
- Frank W Logerfo17 shared
- Leena Pradhan-Nabzdyk9 shared
- Manoj Bhasin6 shared
- David J Mooney4 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Frank W Logerfo$21,342,043
- Manoj Bhasin$2,768,871
Others in their field
Top investigators on “Operative Surgical Procedures”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Larry Arthur$195,389,208
- Norman Wolmark · Nsabp Foundation, Inc.$177,775,854
- Lawrence Corey · Fred Hutchinson Cancer Center$130,508,383
- Richard K. Wilson · Washington University$128,382,063
Research focus
Operative Surgical ProceduresBlood VesselsApoptosisResponseMolecularGene ExpressionThrombosisBaseCytokineAnti-Inflammatory AgentsInjuryPreventOverexpressionGenesHyperplasiaCellsIn VivoIn VitroEffectivenessInflammatoryGene TherapyInflammationResistanceAnti-Inflammatory
Grant awards (42)
Vascular-targeted Atheroprotective Gene therapies to Prevent Vein Graft Failure$753,897
R01 · FY2025 · HL · contact PI
Harvard Longwood Short-Term Research Training in Vascular Surgery$28,786
T35 · FY2025 · HL
Vascular-targeted Atheroprotective Gene therapies to Prevent Vein Graft Failure$775,234
R01 · FY2024 · HL · contact PI
Harvard Longwood Short-Term Research Training in Vascular Surgery$71,224
T35 · FY2024 · HL
Harvard Longwood Research Training in Vascular Surgery$566,240
T32 · FY2023 · HL
Genetic Engineering of Vein Bypass Grafts in Vascular and Cardiovascular Surgery$796,784
R01 · FY2022 · HL
Harvard Longwood Research Training in Vascular Surgery$670,874
T32 · FY2022 · HL
Harvard Longwood Short-Term Research Training in Vascular Surgery$39,955
T35 · FY2022 · HL
Genetic Engineering of Vein Bypass Grafts in Vascular and Cardiovascular Surgery$799,279
R01 · FY2021 · HL
Harvard Longwood Research Training in Vascular Surgery$641,496
T32 · FY2021 · HL
Harvard Longwood Short-Term Research Training in Vascular Surgery$46,505
T35 · FY2021 · HL
Genetic Engineering of Vein Bypass Grafts in Vascular and Cardiovascular Surgery$799,279
R01 · FY2020 · HL
Mechanisms of Prosthetic Arterial Bypass Graft Failure$756,151
R01 · FY2020 · HL
Harvard Longwood Research Training in Vascular Surgery$638,865
T32 · FY2020 · HL
Genetic Engineering of Vein Bypass Grafts in Vascular and Cardiovascular Surgery$799,279
R01 · FY2019 · HL
Mechanisms of Prosthetic Arterial Bypass Graft Failure$756,151
R01 · FY2019 · HL
Harvard Longwood Research Training in Vascular Surgery$606,897
T32 · FY2019 · HL
Bioengineering of vein grafts to resist intimal hyperplasia$218,750
R21 · FY2019 · EB · contact PI
Mechanisms of Prosthetic Arterial Bypass Graft Failure$749,995
R01 · FY2018 · HL
Bioengineering of vein grafts to resist intimal hyperplasia$262,500
R21 · FY2018 · EB · contact PI
Mechanisms of Prosthetic Arterial Bypass Graft Failure$768,102
R01 · FY2017 · HL
Improved liver function and regeneration with A20$349,709
R01 · FY2013 · DK · contact PI
Improved liver function and regeneration with A20$362,392
R01 · FY2012 · DK · contact PI
A20 Gene Polymorphisms in LDLT$217,500
R21 · FY2012 · DK · contact PI
Improved liver function and regeneration with A20$362,392
R01 · FY2011 · DK · contact PI
A20 Gene Polymorphisms in LDLT$261,000
R21 · FY2011 · DK · contact PI
Improved liver function and regeneration with A20$403,920
R01 · FY2010 · DK · contact PI
Vascular Remodeling in Transplant Arteriosclerosis$412,675
R01 · FY2009 · HL · contact PI
Improved liver function and regeneration with A20$408,000
R01 · FY2009 · DK · contact PI
Vascular Remodeling in Transplant Arteriosclerosis$412,675
R01 · FY2008 · HL · contact PI
Improved liver function and regeneration with A20$327,250
R56 · FY2008 · DK · contact PI
Vascular Remodeling in Transplant Arteriosclerosis$412,675
R01 · FY2007 · HL · contact PI
Improved liver function and regeneration with A20$340,920
R01 · FY2007 · DK · contact PI
Vascular Remodeling in Transplant Arteriosclerosis$425,000
R01 · FY2006 · HL · contact PI
Improved liver function and regeneration with A20$351,101
R01 · FY2006 · DK · contact PI
Improved liver function and regeneration with A20$359,550
R01 · FY2005 · DK
Improved liver function and regeneration with A20$359,550
R01 · FY2004 · DK
Improved liver function and regeneration with A20$356,260
R01 · FY2003 · DK
Gene transfer with A20 to improve islet transplantation$170,000
R21 · FY2003 · DK
Gene transfer with A20 to improve islet transplantation$170,000
R21 · FY2002 · DK
MODULATION OF ENDOTHELIAL CELL RESPONSES BY A20$294,697
R01 · FY2001 · HL
MODULATION OF ENDOTHELIAL CELL RESPONSES BY A20$286,116
R01 · FY2000 · HL